Current status of the satisfaction levels of adult patients receiving drugs for atopic dermatitis and chronic urticaria
Abstract Objectives The satisfaction level of adult patients receiving drugs for atopic dermatitis and chronic urticaria is unclear. The objective of this multicenter study was to assess the satisfaction level of adult patients receiving treatment for allergic skin diseases, primarily atopic dermati...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-02-01
|
| Series: | Journal of Cutaneous Immunology and Allergy |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cia2.12200 |
| _version_ | 1797335130376765440 |
|---|---|
| author | Sakae Kaneko Takeshi Nakahara Yasuyuki Sumikawa Atsushi Fukunaga Koji Masuda Takeyasu Kakamu Eishin Morita |
| author_facet | Sakae Kaneko Takeshi Nakahara Yasuyuki Sumikawa Atsushi Fukunaga Koji Masuda Takeyasu Kakamu Eishin Morita |
| author_sort | Sakae Kaneko |
| collection | DOAJ |
| description | Abstract Objectives The satisfaction level of adult patients receiving drugs for atopic dermatitis and chronic urticaria is unclear. The objective of this multicenter study was to assess the satisfaction level of adult patients receiving treatment for allergic skin diseases, primarily atopic dermatitis and chronic urticaria. Methods We developed a self‐administered questionnaire with multiple‐choice questions on patient characteristics, quality of life (QOL), and Abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM‐9). We surveyed 302 patients receiving dermatological treatment. Results The global satisfaction of patients (TSQM‐9) was lower for atopic dermatitis treatment compared with that for chronic urticaria. For atopic dermatitis, dupilumab had higher scores for effectiveness and global satisfaction, whereas topical tacrolimus and moisturizers had higher scores for convenience. For chronic urticaria, omalizumab had higher scores for effectiveness and global satisfaction, while antihistamines had a higher score for convenience. The Dermatology Life Quality Index was significantly associated with treatment effectiveness and global satisfaction, and patient satisfaction improved with the corresponding improvement in the QOL. For atopic dermatitis, satisfaction with dupilumab was higher than that with conventional standard therapy, after the confounding factors were eliminated. However, the same trend was not observed for chronic spontaneous urticaria. Conclusions The satisfaction of the effectiveness for the biologic agents was higher, compared to that with conventional standard therapy. Treatment with biologics is worth exploring for patients who are not satisfied with their existing treatments. |
| first_indexed | 2024-03-08T08:32:26Z |
| format | Article |
| id | doaj.art-81f6da565e0346bea5b571a3fba2aca0 |
| institution | Directory Open Access Journal |
| issn | 2574-4593 |
| language | English |
| last_indexed | 2024-03-08T08:32:26Z |
| publishDate | 2022-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Journal of Cutaneous Immunology and Allergy |
| spelling | doaj.art-81f6da565e0346bea5b571a3fba2aca02024-02-02T02:37:44ZengFrontiers Media S.A.Journal of Cutaneous Immunology and Allergy2574-45932022-02-015141110.1002/cia2.12200Current status of the satisfaction levels of adult patients receiving drugs for atopic dermatitis and chronic urticariaSakae Kaneko0Takeshi Nakahara1Yasuyuki Sumikawa2Atsushi Fukunaga3Koji Masuda4Takeyasu Kakamu5Eishin Morita6Department of Dermatology Masuda Red Cross Hospital Masuda JapanDivision of Skin Surface Sensing Department of Dermatology Graduate School of Medical Sciences Kyushu University Fukuoka JapanDepartment of Dermatology School of Medicine Sapporo Medical University Sapporo JapanDivision of Dermatology Department of Internal Related Kobe University Graduate School of Medicine Kobe JapanDepartment of Dermatology Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Hygiene & Preventive Medicine Fukushima Medical University School of Medicine Fukushima JapanDepartment of Dermatology Faculty of Medicine Shimane University Izumo JapanAbstract Objectives The satisfaction level of adult patients receiving drugs for atopic dermatitis and chronic urticaria is unclear. The objective of this multicenter study was to assess the satisfaction level of adult patients receiving treatment for allergic skin diseases, primarily atopic dermatitis and chronic urticaria. Methods We developed a self‐administered questionnaire with multiple‐choice questions on patient characteristics, quality of life (QOL), and Abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM‐9). We surveyed 302 patients receiving dermatological treatment. Results The global satisfaction of patients (TSQM‐9) was lower for atopic dermatitis treatment compared with that for chronic urticaria. For atopic dermatitis, dupilumab had higher scores for effectiveness and global satisfaction, whereas topical tacrolimus and moisturizers had higher scores for convenience. For chronic urticaria, omalizumab had higher scores for effectiveness and global satisfaction, while antihistamines had a higher score for convenience. The Dermatology Life Quality Index was significantly associated with treatment effectiveness and global satisfaction, and patient satisfaction improved with the corresponding improvement in the QOL. For atopic dermatitis, satisfaction with dupilumab was higher than that with conventional standard therapy, after the confounding factors were eliminated. However, the same trend was not observed for chronic spontaneous urticaria. Conclusions The satisfaction of the effectiveness for the biologic agents was higher, compared to that with conventional standard therapy. Treatment with biologics is worth exploring for patients who are not satisfied with their existing treatments.https://doi.org/10.1002/cia2.12200atopic dermatitisquality of lifetreatment effectivenesstreatment satisfactionurticaria |
| spellingShingle | Sakae Kaneko Takeshi Nakahara Yasuyuki Sumikawa Atsushi Fukunaga Koji Masuda Takeyasu Kakamu Eishin Morita Current status of the satisfaction levels of adult patients receiving drugs for atopic dermatitis and chronic urticaria Journal of Cutaneous Immunology and Allergy atopic dermatitis quality of life treatment effectiveness treatment satisfaction urticaria |
| title | Current status of the satisfaction levels of adult patients receiving drugs for atopic dermatitis and chronic urticaria |
| title_full | Current status of the satisfaction levels of adult patients receiving drugs for atopic dermatitis and chronic urticaria |
| title_fullStr | Current status of the satisfaction levels of adult patients receiving drugs for atopic dermatitis and chronic urticaria |
| title_full_unstemmed | Current status of the satisfaction levels of adult patients receiving drugs for atopic dermatitis and chronic urticaria |
| title_short | Current status of the satisfaction levels of adult patients receiving drugs for atopic dermatitis and chronic urticaria |
| title_sort | current status of the satisfaction levels of adult patients receiving drugs for atopic dermatitis and chronic urticaria |
| topic | atopic dermatitis quality of life treatment effectiveness treatment satisfaction urticaria |
| url | https://doi.org/10.1002/cia2.12200 |
| work_keys_str_mv | AT sakaekaneko currentstatusofthesatisfactionlevelsofadultpatientsreceivingdrugsforatopicdermatitisandchronicurticaria AT takeshinakahara currentstatusofthesatisfactionlevelsofadultpatientsreceivingdrugsforatopicdermatitisandchronicurticaria AT yasuyukisumikawa currentstatusofthesatisfactionlevelsofadultpatientsreceivingdrugsforatopicdermatitisandchronicurticaria AT atsushifukunaga currentstatusofthesatisfactionlevelsofadultpatientsreceivingdrugsforatopicdermatitisandchronicurticaria AT kojimasuda currentstatusofthesatisfactionlevelsofadultpatientsreceivingdrugsforatopicdermatitisandchronicurticaria AT takeyasukakamu currentstatusofthesatisfactionlevelsofadultpatientsreceivingdrugsforatopicdermatitisandchronicurticaria AT eishinmorita currentstatusofthesatisfactionlevelsofadultpatientsreceivingdrugsforatopicdermatitisandchronicurticaria |